Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells

Stem Cells and Development

Volumn 19, Issue 2, 2010, Pages 247-257

  Kao, Chung Lan ^a,b   Tai, Lung Kuo ^a,b   Chiou, Shih Hwa ^a,b   Chen, Yi Jen ^a,b,c   Lee, Kung Hsiung ^d   Chou, Shih Jie ^b   Chang, Yuh Lih ^a,b   Chang, Chia Ming ^a,b,c   Chen, Shih Jen ^a,b   Ku, Hung Hai ^a   Li, Hsin Yang ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c Georgetown Univ School of Medicine   (Taiwan)

^d ANIMAL TECHNOLOGY INSTITUTE TAIWAN   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; DEXAMETHASONE; GLUCOCORTICOID; GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ADIPOCYTE; ANIMAL CELL; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; EMBRYONIC STEM CELL; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; MINERALIZATION; MOUSE; NANOANALYSIS; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TERATOMA; UPREGULATION; YOUNG MODULUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; DEXAMETHASONE; EMBRYONIC STEM CELLS; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; MICE; MICE, NUDE; MULTIPOTENT STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES; TRANSDUCTION, GENETIC;

IPS; MURINAE;

EID: 77649136214     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0186     Document Type: Article

References (40)

1. Petersen BE, WC Bowen, KD Patrene, WM Mars, AK Sullivan, N Murase, SS Boggs, JS Greenberger and JP Goff. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170.
2. Cancedda R, G Bianchi, A Derubeis and R Quarto. (2003). Cell therapy for bone disease: a review of current status. Stem Cells 21:610-619.
3. Yang DC, HJ Tsay, SY Lin, SH Chiou, MJ Li, TJ Chang and SC Hung. (2008). cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS ONE 3:e1540.
4. Chiou SH, CL Kao, CH Peng, SJ Chen, YW Tarng, HH Ku, YC Chen, YM Shyr, RS Liu, CJ Hsu, DM Yang, WM Hsu, CD Kuo and CH Lee. (2005). A novel in vitro retinal differentiation model by co-culturing adult human bone marrow stem cells with retinal pigmented epithelium cells. Biochem Biophys Res Commun 326:578-585.
5. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
6. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
7. Xu D, Z Alipio, LM Fink, DM Adcock, J Yang, DC Ward and Y Ma. (2009). Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci USA 106: 808-813.
8. Das S and DK Das. (2007). Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 6:168-173.
9. de la Lastra CA and I Villegas. (2005). Resveratrol as an antiinflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49:405-430.
10. Bastianetto S, WH Zheng and R Quirion. (2000). Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 131:711-720.
11. Bäckesjö CM, Y Li, U Lindgren and LA Haldosen. (2006). Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res 21:993-1002.
12. Kundu JK and YJ Surh. (2004). Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 555:65-80.
13. Kundu JK and YJ Surh. (2008). Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269:243-261.
14. Zhao XY, GY Li, Y Liu, LM Chai, JX Chen, Y Zhang, ZM Du, YJ Lu and BF Yang. (2008). Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br J Pharmacol 154:105-113.
15. Pelling AE, Y Li, W Shi and JK Gimzewski. (2005). Nanoscale visualization and characterization of Myxococcus xanthus cells with atomic force microscopy. Proc Natl Acad Sci USA 102:6484-6489.
16. El Kirat K, I Burton, V Dupres and YF Dufrene. (2005). Sample preparation procedures for biological atomic force microscopy. J Microsc 218:199-207.
17. Sugawara Y, R Ando, H Kamioka, Y Ishihara, SA Murshid, K Hashimoto, N Kataoka, K Tsujioka, F Kajiya, T Yamashiro and T Takano-Yamamoto. (2008). The alteration of a mechanical property of bone cells during the process of changing from osteoblasts to osteocytes. Bone 43:19-24.
18. Hengsberger S, A Kulik and P Zysset. (2001). A combined atomic force microscopy and nanoindentation technique to investigate the elastic properties of bone structural units. Eur Cell Mater 1:12-17.
19. Costa KD. (2003). Single-cell elastography: probing for disease with the atomic force microscope. Dis Markers 19:139-154.
20. Lin HT, CL Kao, KH Lee, YL Chang, SH Chiou, FT Tsai, TH Tsai, DC Sheu, LL Ho and HH Ku. (2007). Enhancement of insulin-producing cell differentiation from embryonic stem cells using pax4-nucleofection method. World J Gastroenterol 13:1672-1679.
21. Chiou SH, HH Ku, TH Tsai, HL Lin, LH Chen, CS Chien, LL Ho, CH Lee and YL Chang. (2006). Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. Br J Pharmacol 148:587-598.
22. Wu CW, YH Ping, JC Yen, CY Chang, SF Wang, CL Yeh, CW Chi and HC Lee. (2007). Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol 220:243-251.
23. Canalis E, G Mazziotti, A Giustina and JP Bilezikian. (2007). Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328.
24. Plotkin LI, SC Manolagas and T Bellido. (2007). Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinasemediated survival. Evidence for inside-out signaling leading to anoikis. J Biol Chem 282:24120-24130.
25. Knoepfler PS. (2009). Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27:1050-1056.
26. Saruwatari L, H Aita, F Butz, HK Nakamura, J Ouyang, Y Yang, WA Chiou and T Ogawa. (2005). Osteoblasts generate harder, stiffer, and more delamination-resistant mineralized tissue on titanium than on polystyrene, associated with distinct tissue micro-and ultrastructure. J Bone Miner Res 20:2002-2016.
27. Lippert F, DM Parker and KD Jandt. (2004). In vitro demineralization/ remineralization cycles at human tooth enamel surfaces investigated by AFM and nanoindentation. J Colloid Interface Sci 280:442-448.
28. Thompson JB, JH Kindt, B Drake, HG Hansma, DE Morse and PK Hansma. (2001). Bone indentation recovery time correlates with bond reforming time. Nature 414:773-776.
29. Docheva D, D Padula, C Popov, W Mutschler, H ClausenSchaumann and M Schieker. (2008). Researching into the cellular shape, volume and elasticity of mesenchymal stem cells, osteoblasts and osteosarcoma cells by atomic force microscopy. J Cell Mol Med 12:537-552.
30. Jilka RL, RS Weinstein, AM Parfitt and SC Manolagas. (2007). Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res 22:1492-1501.
31. Brito PM, NF Simoes, LM Almeida and TC Dinis. (2008). Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: a role for Bcl-2. Apoptosis 13:1043-1053.
32. Dudley J, S Das, S Mukherjee and DK Das. (2008). Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem 20:443-452.
33. Sohal RS and R Weindruch. (1996). Oxidative stress, caloric restriction, and aging. Science 273:59-63.
34. Ito K, A Hirao, F Arai, K Takubo, S Matsuoka, K Miyamoto, M Ohmura, K Naka, K Hosokawa, Y Ikeda and T Suda. (2006). Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12:446-451.
35. Robb EL, MM Page, BE Wiens and JA Stuart. (2008). Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem Biophys Res Commun 367:406-412.
36. Robb EL, L Winkelmolen, N Visanji, J Brotchie and JA Stuart. (2008). Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem Biophys Res Commun 372:254-259.
37. Hwang JT, DY Kwon, OJ Park and MS Kim. (2008). Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr 2:323-326.
38. Wang RH, K Sengupta, C Li, HS Kim, L Cao, C Xiao, S Kim, X Xu, Y Zheng, B Chilton, R Jia, ZM Zheng, E Appella, XW Wang, T Ried and CX Deng. (2008). Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14:312-323.
39. Wang RH, Y Zheng, HS Kim, X Xu, L Cao, T Luhasen, MH Lee, C Xiao, A Vassilopoulos, W Chen, K Gardner, YG Man, MC Hung, T Finkel and CX Deng. (2008). Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell 32:11-20.
40. Kao CL, PI Huang, PH Tsai, ML Tsai, JF Lo, YY Lee, YJ Chen, YW Chen and SH Chiou. (2009). Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys 74:219-228.